Infectious Complication Following Midface Reconstruction With Calcified Triglyceride

Area of Science:

• Reconstructive surgery
• Biomaterials science
• Infectious disease

Background:

• Calcified triglyceride bone cement is used in reconstructive surgery.
• Post-traumatic midface reconstruction presents unique challenges.
• Infectious complications can arise from biomaterial use.

Observation:

• A case report details an infectious complication arising from the use of calcified triglyceride bone cement.
• The infection was directly related to the presence of the bone cement material.
• The infected cement necessitated surgical removal to manage the complication.

Findings:

• Infectious complications can occur with the use of calcified triglyceride bone cement in midface reconstruction.
• Surgical removal of infected bone cement is a critical step in managing such complications.
• Subsequent procedures were required to address the residual facial deformity after cement removal.

Implications:

• Bone cement, particularly calcified triglyceride formulations, should be used with caution in areas adjacent to or within the paranasal sinuses.
• Careful patient selection and surgical technique are paramount to minimize infection risk.
• Further research into the long-term safety and efficacy of bone cements in craniofacial reconstruction is warranted.